Why was there a high classification? Doping by athletes! Not research. Not medicine innovation. So some doctors and research shows prescribing DROPS.
State registries intimidate doctors and pharmacists. They may not carry at all. Limit to 30 days. Require more aggressive monitoring demanded by a state board.
Patients feel looked at like drug addicts. Some pharmacists DO act like DEA agents going after a Drug cartel.
THE NEWER RESEARCH SHOWS LETTING SOME CRAZY JOCKS TO CONTROL MEDICINE AND HURT IMMENSE MILLIONS. IS NUTS.
AND YOU STILL SEE THIS HEART DEATH OR PROSTATE CANCER NONSENSE ON “EDUCATION” SITES AS OF MANY MONTHS LATER.
RESULTS
Results: We identified 35 trials (5601 randomised participants).
**There was no difference between the testosterone replacement therapy group (120/1601, 7.5%) and placebo group (110/1519, 7.2%) in the incidence of cardiovascular and/or cerebrovascular events [HEART ATTACKS AND STROKES].
**Testosterone replacement therapy improved quality of life
**And sexual function [improved] in almost all patient subgroups.
**In the testosterone replacement therapy group, serum testosterone was higher while serum cholesterol, triglycerides, haemoglobin and haematocrit were all lower.
**We identified several themes from five qualitative studies showing how symptoms of low testosterone affect men’s lives and their experience of treatment. The cost-effectiveness of testosterone replacement therapy was dependent on whether uncertain effects on all-cause mortality were included in the model, and on the approach used to estimate the health state utility increment associated with testosterone replacement therapy, which might have been driven by improvements in symptoms such as sexual dysfunction and low mood.
Limitations: A meaningful evaluation of mortality was hampered by the limited number of defined events. Definition and reporting of cardiovascular and cerebrovascular events and methods for testosterone measurement varied across trials.
Conclusions:
Our findings do not support a relationship between testosterone replacement therapy and cardiovascular/cerebrovascular events in the short-to-medium term.
Testosterone replacement therapy improves sexual function and quality of life without adverse effects on blood pressure, serum lipids or glycaemic markers.
TESTOSTERONE REPLACEMENT CAUSES INCREASED:
VIGOR
ENERGY
“I FEEL LIKE MYSELF AGAIN”
COPING
CONCENTRATION
—HIGHER TESTOSTERONE, HIGHER FREE TESTOSTERONE AND HIGHER DHT IS ASSOCIATED WITH LOWER PROSTATE CANCER—
***TESTOSTERONE LOWERS
DIABETES
OBESITY
DEPRESSION
OSTEOPENIA/OSTEOPOROSIS
Cruickshank M, Hudson J, Hernández R, Aceves-Martins M, Quinton R, Gillies K, Aucott LS, Kennedy C, Manson P, Oliver N, Wu F, Bhattacharya S, Dhillo WS, Jayasena CN, Brazzelli M. The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation. Health Technol Assess. 2024 Aug;28(43):1-210. doi: 10.3310/JRYT3981. PMID: 39248210; PMCID: PMC11404359. THIS IS LARGEST PLACEBO CONTROLLED TRIAL ON TESTOSTERONE WITH HYPOGONADISM.
ONE ISSUE: TESTOSTERONE ALONE CAN LOWER SPERM WHICH IS WELL KNOWN FOR DECADES AND EASILY ADDRESSED.